findmyKOL
Clinical trialNCT01242527CompletedPhase 2/PHASE3Interventional

Epanova® for Lowering Very High Triglycerides

SponsorAstraZenecaEnrollment399Severe Hypertriglyceridemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

68 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Facility name not stated

    Copenhagen, Denmark

  • Facility name not stated

    Gentofte Municipality, Denmark

  • Facility name not stated

    Herlev, Denmark

  • Facility name not stated

    Viborg, Denmark

Hungary
  • Facility name not stated

    Baja, Hungary

  • Facility name not stated

    Budapest, Hungary

  • Facility name not stated

    Budapest, Hungary

  • Facility name not stated

    Budapest, Hungary

  • Facility name not stated

    Debrecen, Hungary

  • Facility name not stated

    Debrecen, Hungary

  • Facility name not stated

    Szikszó, Hungary

  • Facility name not stated

    Székesfehérvár, Hungary

  • Facility name not stated

    Sátoraljaújhely, Hungary

India
  • Facility name not stated

    Karnāl, Haryana, India

  • Facility name not stated

    Bangalore, Karnataka, India

  • Facility name not stated

    Bangalore, Karnataka, India

  • Facility name not stated

    Bangalore, Karnataka, India

  • Facility name not stated

    Banswada, Karnataka, India

  • Facility name not stated

    Indore, Madhya Pradesh, India

  • Facility name not stated

    Pune, Maharashtra, India

  • Facility name not stated

    Jaipur, Rajasthan, India

  • Facility name not stated

    Chennai, Tamil Nadu, India

  • Facility name not stated

    Surat, India

Netherlands
  • Facility name not stated

    Amsterdam, Netherlands

  • Facility name not stated

    Groningen, Netherlands

  • Facility name not stated

    Rotterdam, Netherlands

  • Facility name not stated

    Rotterdam, Netherlands

  • Facility name not stated

    Utrecht, Netherlands

Russia
  • Facility name not stated

    Moscow, Russia

  • Facility name not stated

    Novosibirsk, Russia

  • Facility name not stated

    Saint Petersburg, Russia

  • Facility name not stated

    Saint Petersburg, Russia

Ukraine
  • Facility name not stated

    Kharkiv, Ukraine

  • Facility name not stated

    Kharkiv, Ukraine

  • Facility name not stated

    Kharkiv, Ukraine

  • Facility name not stated

    Kiev, Ukraine

  • Facility name not stated

    Kiev, Ukraine

  • Facility name not stated

    Zaporizhzhya, Ukraine

United States
  • Facility name not stated

    National City, California, United States

  • Facility name not stated

    Sacramento, California, United States

28 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2011
Primary completion
31 Mar 2012
Completion
30 Apr 2012
Last update posted
4 Aug 2016
Registered enrollment
399
Registry id
NCT01242527

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.